A detailed history of Aqr Capital Management LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 202,241 shares of AUPH stock, worth $1.47 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
202,241
Holding current value
$1.47 Million
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$4.81 - $5.78 $972,779 - $1.17 Million
202,241 New
202,241 $1.15 Million
Q4 2023

Feb 14, 2024

BUY
$7.13 - $9.49 $20,170 - $26,847
2,829 Added 15.2%
21,435 $192,000
Q3 2023

Nov 14, 2023

BUY
$7.77 - $12.27 $57,855 - $91,362
7,446 Added 66.72%
18,606 $144,000
Q2 2023

Aug 14, 2023

SELL
$8.96 - $11.69 $111,587 - $145,587
-12,454 Reduced 52.74%
11,160 $108,000
Q1 2023

May 15, 2023

BUY
$5.94 - $11.27 $69,248 - $131,385
11,658 Added 97.51%
23,614 $258,000
Q4 2022

Feb 14, 2023

BUY
$4.11 - $8.14 $49,139 - $97,321
11,956 New
11,956 $51,000

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.03B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.